Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Luigi Cerbone"'
Autor:
Eleonora Faccioli, Federica Grosso, Andrea Dell’Amore, Sara Delfanti, Giovanni Zambello, Luigi Cerbone, Gianluca Canu, Antonina De Angelis, Viola Sambataro, Federica Pezzuto, Paola Barbieri, Giulia Pasello, Fiorella Calabrese, Federico Rea
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The role of immunotherapy in the multimodal treatment for pleural mesothelioma (PM) is still under investigation, particularly in the preoperative setting. Pathological complete response (pCR) has been previously described after chemotherapy and immu
Externí odkaz:
https://doaj.org/article/eb76bdc9daea45e5b7ca1a3bd9979572
Autor:
Luana Calabrò, Giuseppe Bronte, Federica Grosso, Luigi Cerbone, Angelo Delmonte, Fabio Nicolini, Massimiliano Mazza, Anna Maria Di Giacomo, Alessia Covre, Maria Fortunata Lofiego, Lucio Crinò, Michele Maio
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Pleural mesothelioma (PM) is an aggressive and rare disease, characterized by a very poor prognosis. For almost two decades, the world standard treatment regimen for unresectable PM has consisted of a platinum-based drug plus pemetrexed, leading to a
Externí odkaz:
https://doaj.org/article/8927fd98d7b248cbac772e012b06e713
Autor:
Luigi Cerbone, Sara Delfanti, Antonina M. De Angelis, Stefania Crivellari, Francesco Boccuzzi, Angela Cimorelli, Marinella Bertolotti, Luisella Righi, Pietro Bertino, Federica Grosso
Publikováno v:
Thoracic Cancer, Vol 14, Iss 5, Pp 524-527 (2023)
Abstract Pleural mesothelioma is a rare disease with a dismal prognosis and few therapeutic options. Until recently the median overall survival for a pleural mesothelioma patient was up to 2 years, with few exceptional cases of patients achieving a l
Externí odkaz:
https://doaj.org/article/ea61cb306e7440dc858c5bd2e7b300db
Autor:
Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, Matteo Santoni, Veronica Murianni, Ugo De Giorgi, Giuseppe Procopio, Camillo Porta, Michele Milella, Umberto Basso, Francesco Massari, Marco Maruzzo, Roberto Iacovelli, Nicola Battelli, Luca Carmisciano, Giuseppe Luigi Banna, Sebastiano Buti, Giuseppe Fornarini
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: The addition of neutrophil-to-lymphocyte ratio (NLR) and bone metastases to the International Metastatic RCC Database Consortium (IMDC) score (by the Meet-URO score) has been shown to better stratify pretreated metastatic renal cell carci
Externí odkaz:
https://doaj.org/article/e61b5567e94341248f175a705d2cf564
Autor:
Veronica Murianni, Luigi Cerbone, Pasquale Rescigno, Fabio Catalano, Alessandra Damassi, Malvina Cremante, Annalice Gandini, Silvia Puglisi, Guido Pesola, Giuseppe Luigi Banna, Sebastiano Buti, Alessio Signori, Giuseppe Fornarini, Sara Elena Rebuzzi
Publikováno v:
Immunotherapy. 14:1419-1427
Immune checkpoint inhibitors have significantly improved the therapeutic scenario of many different advanced malignancies and could be an effective treatment strategy in synchronous or metachronous tumors. The authors describe the clinical case of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc872d222d61f81ebde53e9d7eb0e23f
https://doi.org/10.2217/imt-2022-0150
https://doi.org/10.2217/imt-2022-0150
Autor:
Sergey I. Nikolaev, Daniel Gautheret, Paul-Henry Cournède, Fabrice André, Luc Friboulet, Benjamin Besse, Yohann Loriot, Antoine Lainé, Laura Mezquita, Gérôme Jules-Clément, Antoine Hollebecque, Stefan Michiels, Leonardo Panunzi, Ismael Padioleau, Véronique Scott, Loic Verlingue, Guillaume Grisay, Marc Deloger, Luigi Cerbone, Konstantin Gunbin, Andrey A. Yurchenko, Julien Viot, Yoann Pradat
These figures provide complementary information for the figures presented in the main text and illustrations of the methods section.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1e3a740d395bcf770a80c481726b1e
https://doi.org/10.1158/2159-8290.22758879.v1
https://doi.org/10.1158/2159-8290.22758879.v1
Autor:
Laurence Zitvogel, Lisa Derosa, Markus Maeurer, Bernard La Scola, Guido Kroemer, Odile Launay, Emma Guttman-Yassky, Florence Fenollar, Sophie Caillat-Zucman, Mathieu F. Chevalier, Juliette Villemonteix, Fabrice André, Miriam Merad, Jean-Charles Soria, Jean-Yves Blay, Frank Griscelli, Aurélien Marabelle, Florian Scotté, Mansouria Merad, Jean-Philippe Spano, Bertrand Gachot, Eric Deutsch, Nathalie Droin, Marc Deloger, Pernelle Lavaud, Emeline Colomba, Fanny Pommeret, Emmanuelle Gallois, Caroline Pradon, Yeriel Estrada, Benjamin Ungar, Alexandre Trubert, Fabrice Barlesi, Guy Gorochov, Makoto Miyara, Abdelhakim Ahmed-Belkacem, Lydia Meziani, Nadine Benhamouda, Eric Tartour, Pierre Ly, Caroline Flament, Eugenie Pizzato, Safae Terrisse, François-Xavier Danlos, Marianne Gazzano, Benoît Kloeckner, Alice Bernard-Tessier, Ariane Laparra, Joana R. Lérias, Luigi Cerbone, Marion Picard, Camille Bigenwald, Roxanne Birebent, Gladys Ferrere, Arthur Geraud, Agathe Dubuisson, Cléa Melenotte, Cassandra Thelemaque, Eric de Sousa, Carolina Alves Costa Silva, Damien Drubay, Marine Mazzenga, Agathe Carrier, Yacine Haddad, Anne-Gaëlle Goubet, Imran Lahmar, Jean-Eudes Fahrner
Supplementary Figure from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67703e4793a9d4e21524188afe4f7eec
https://doi.org/10.1158/2159-8290.22540913.v1
https://doi.org/10.1158/2159-8290.22540913.v1
Autor:
Laurence Zitvogel, Lisa Derosa, Markus Maeurer, Bernard La Scola, Guido Kroemer, Odile Launay, Emma Guttman-Yassky, Florence Fenollar, Sophie Caillat-Zucman, Mathieu F. Chevalier, Juliette Villemonteix, Fabrice André, Miriam Merad, Jean-Charles Soria, Jean-Yves Blay, Frank Griscelli, Aurélien Marabelle, Florian Scotté, Mansouria Merad, Jean-Philippe Spano, Bertrand Gachot, Eric Deutsch, Nathalie Droin, Marc Deloger, Pernelle Lavaud, Emeline Colomba, Fanny Pommeret, Emmanuelle Gallois, Caroline Pradon, Yeriel Estrada, Benjamin Ungar, Alexandre Trubert, Fabrice Barlesi, Guy Gorochov, Makoto Miyara, Abdelhakim Ahmed-Belkacem, Lydia Meziani, Nadine Benhamouda, Eric Tartour, Pierre Ly, Caroline Flament, Eugenie Pizzato, Safae Terrisse, François-Xavier Danlos, Marianne Gazzano, Benoît Kloeckner, Alice Bernard-Tessier, Ariane Laparra, Joana R. Lérias, Luigi Cerbone, Marion Picard, Camille Bigenwald, Roxanne Birebent, Gladys Ferrere, Arthur Geraud, Agathe Dubuisson, Cléa Melenotte, Cassandra Thelemaque, Eric de Sousa, Carolina Alves Costa Silva, Damien Drubay, Marine Mazzenga, Agathe Carrier, Yacine Haddad, Anne-Gaëlle Goubet, Imran Lahmar, Jean-Eudes Fahrner
Supplementary Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0348b8c76ae6b0fa89b61c11d02aad6a
https://doi.org/10.1158/2159-8290.22540916
https://doi.org/10.1158/2159-8290.22540916
Autor:
Mihaela Aldea, Marco Tagliamento, Arnaud Bayle, Damien Vasseur, Véronique Vergé, Arianna Marinello, François-Xavier Danlos, Felix Blanc-Durand, Elsa Bernard, Luigi Cerbone, Maria Fernanda Mosele, Aline Renneville, Julien Hadoux, Yohann Loriot, Madona Sakkal, Aurore Vozy, Clementine Sarkozy, Cristina Smolenschi, Claudio Nicotra, Patricia Martin-Romano, Clementine Boccon-Gibod, Wafikaamira Habza, Julien Lazarovici, Santiago Ponce, Antoine Hollebecque, Christophe Marzac, Ludovic Lacroix, Fabrice Barlesi, Fabrice André, Benjamin Besse, Etienne Rouleau, Antoine Italiano, Jean-Baptiste Micol
Publikováno v:
JCO Precision Oncology.
PURPOSE High-risk clonal hematopoiesis (CH) is frequently incidentally found in patients with solid tumors undergoing plasma cell–free DNA sequencing. Here, we aimed to determine if the incidental detection of high-risk CH by liquid biopsy may reve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba645f79725b4e856c17d01b02a90235
https://doi.org/10.1200/po.22.00583
https://doi.org/10.1200/po.22.00583
Autor:
Yoann Pradat, Julien Viot, Andrey A. Yurchenko, Konstantin Gunbin, Luigi Cerbone, Marc Deloger, Guillaume Grisay, Loic Verlingue, Véronique Scott, Ismael Padioleau, Leonardo Panunzi, Stefan Michiels, Antoine Hollebecque, Gérôme Jules-Clément, Laura Mezquita, Antoine Lainé, Yohann Loriot, Benjamin Besse, Luc Friboulet, Fabrice André, Paul-Henry Cournède, Daniel Gautheret, Sergey I. Nikolaev
Publikováno v:
Cancer discovery
Cancer discovery, 2023, 13 (5), pp.1116-1143. ⟨10.1158/2159-8290.CD-22-0966⟩
Cancer discovery, 2023, 13 (5), pp.1116-1143. ⟨10.1158/2159-8290.CD-22-0966⟩
Metastatic relapse after treatment is the leading cause of cancer mortality, and known resistance mechanisms are missing for most treatments administered to patients. To bridge this gap, we analyze a pan-cancer cohort (META-PRISM) of 1,031 refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76a1d26900dfcde3ec17cb2687023db8
https://hal.science/hal-04122846
https://hal.science/hal-04122846